相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1
Cedric Le May et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein
Agnes Telbisz et al.
BIOCHEMICAL JOURNAL (2013)
Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases
Miao Hu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells
Kenneth K. W. To et al.
PEPTIDES (2013)
Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial
Daniel I. Chasman et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
PXR and NF-κB correlate with the inducing effects of IL-1β and TNF-α on ABCG2 expression in breast cancer cell lines
Obeid M. Malekshah et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins
Miao Hu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes
Katharine Howe et al.
XENOBIOTICA (2011)
Transporter Pharmacogenetics and Statin Toxicity
M. Niemi
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin
B. Tomlinson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients
Miao Hu et al.
PHARMACOGENETICS AND GENOMICS (2010)
Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays
Csilla Hegedus et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
J. E. Keskitalo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs
Alice Cristina Rodrigues et al.
PHARMACOGENOMICS (2009)
Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simastatin
Jenni E. Keskitalo et al.
PHARMACOGENOMICS (2009)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter
Agnes Telbisz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro
Caroline Henrike Storch et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells
Caroline Henrike Storch et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones
Tomohiro Ando et al.
DRUG METABOLISM AND DISPOSITION (2007)
Cholesterol potentiates ABCG2 activity in a heterologous expression system:: Improved in vitro model to study function of human ABCG2
A. Pal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol
Yasuhisa Kimura et al.
BIOCHEMICAL JOURNAL (2007)
Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies
Raphael Zidovetzki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Down-regulation of ABCB1 transporter by atorvastatin in a human hepatoma cell line and in human peripheral blood mononuclear cells
Alice Cristina Rodrigues et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis
W Le Goff et al.
JOURNAL OF LIPID RESEARCH (2006)
Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver
N Albermann et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells
J Troost et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane
A Garrigues et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
